http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-755240-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7105207ca740add5aa1300e0c7f20a8a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee51a60b9eacd79a3ae44d63e52dfe3 |
| publicationDate | 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-755240-B2 |
| titleOfInvention | Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| priorityDate | 1991-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.